Filing Details

Accession Number:
0001225208-22-002932
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-22 16:46:51
Reporting Period:
2022-02-17
Accepted Time:
2022-02-22 16:46:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529751 A David Pierce 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp Pres Medsurg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-17 3,333 $0.00 3,333 No 4 M Direct
Common Stock Disposition 2022-02-17 979 $42.83 2,354 No 4 F Direct
Common Stock Acquisiton 2022-02-18 2,668 $0.00 5,022 No 4 M Direct
Common Stock Disposition 2022-02-18 784 $42.55 4,238 No 4 F Direct
Common Stock Disposition 2022-02-18 2,354 $42.88 1,884 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-02-17 3,333 $0.00 3,333 $0.00
Common Stock Deferred Stock Units Disposition 2022-02-18 2,668 $0.00 2,668 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2025-02-17 No 4 M Direct
5,337 2024-02-18 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  2. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  3. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
  4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
  5. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.